Top
US_Flag An official website of the United States government Here's how you know
GOV

The .gov means it's official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

LOCK

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

 
U.S. Food & Drug Administration
Continuing Education and Accreditation
Division of Learning and Organizational Development
Center for Drug Evaluation and Research

FDA Drug Safety Podcast: Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity

Enroll
Step Status
Educational Content ✘
Posttest ✘
Evaluation ✘
Starts On: Tue, 4/9/24: 12:00 AM EDT
Ends On: Thu, 4/8/27: 12:00 AM EDT
Type: Enduring Material
Credits: 0.5
Description: This enduring material focuses on FDA's evaluation of reports of suicidal thoughts or actions in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs). GLP-1 RAs are used to treat people with type 2 diabetes or to help those with obesity or overweight to lose weight. The presenter will discuss the preliminary evaluation and the limitations of the available data.
Objectives:
  • Explain the types of data analysis conducted during the preliminary evaluation.
  • Discuss FDA’s preliminary evaluation of reports of suicidal thoughts or actions in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
  • Review recommendations for healthcare providers when treating patients with these medications .
Additional Information: Review the Activity Announcement for additional details: Announcement Form